Ascensia Diabetes Care Announces Global Integration Of The Eversense CGM System With Apple Health
The Eversense CGM app has been updated globally to seamlessly integrate with Apple HealthTM, according to Ascensia Diabetes Care, a global diabetes care company that produces the CONTOUR Blood Glucose Monitoring (BGM) System portfolio and distributes the Eversense Continuous Glucose Monitoring (CGM) System. As a result, users of Eversense CGM Systems who have diabetes will now have the ability to view their glucose readings in the Apple Health app together with other health indicators on the widely used health and wellbeing platform for the iPhone.
The Eversense E3, created by Senseonics Holdings, Inc., is the longest-lasting CGM currently on the market, with sensor wear lasting up to 6 months. It is extraordinarily accurate and totally implanted. Data from the system is sent to the Eversense CGM App, where users may examine, analyse, and share glucose data with ease and receive notifications of changes and trends. With this update, users may now opt to display their data in Apple Health, where they can also examine health data gathered by their iPhone through various apps and wearables, in all markets where Eversense is offered. By enabling Eversense users to conveniently examine their glucose data within their larger digital health context, this connection intends to improve diabetes management.
“We are pleased to integrate the Eversense CGM system with Apple HealthTM, giving our users more choice on how they view and use data for their diabetes management”, “Supplementing the benefits of the Eversense CGM App, this update allows people with diabetes to access glucose data alongside other important metrics to provide a more holistic view of their health and wellbeing. In an increasingly digital world, it is important that medical devices and digital solutions are interoperable, and we are excited to further embed Eversense into the connected healthcare ecosystem.”
Elaine Anderson, Head of the Eversense CGM Business Unit at Ascensia Diabetes Care
Ascensia Diabetes Care is working with Senseonics to make Eversense interoperable with new diabetes devices and online platforms because it is devoted to giving patients access to information, data, and advanced analytics. Together, the businesses are carrying out strategies to gain iCGM (integrated CGM) approval, integrate Eversense with automated insulin delivery (AID) systems, and pursue industry partnerships that will maximise its advantages for the diabetes community.
For More Healthcare News Click Here
